Claims for Patent: 11,676,691

Summary for Patent: 11,676,691

Title:	Storage and dispensing devices for administration of oral transmucosal dosage forms
Abstract:	Dispensing devices and systems for oral transmucosal administration of small volume drug dosage forms to the oral mucosa are provided. The dispensing device may be a single dose applicator (SDA), or an electromechanical device comprising a means for patient identification such as a wrist worn RFID tag and annular bidirectional antenna together with a lock-out feature.
Inventor(s):	Andrew Poutiatine, Bruce Edwards, Charles Rampersaud, Pamela Palmer, Bradley Blackwood, Benjamin K. Yaffe
Assignee:	CITO MECHANICAL DESIGN Inc , Vertical Pharmaceuticals LLC
Application Number:	US17/150,450
Patent Claims:	1. An apparatus, comprising: a housing defining an actuation pathway, the housing having a distal end portion; and a delivery member, at least a portion of the delivery member being disposed within the actuation pathway such that a distal end portion of the delivery member and the distal end portion of the housing define a volume configured to contain a drug-containing tablet, the delivery member configured to move relative to the housing in a distal direction to expel the drug-containing tablet from the volume, the distal end portion of the delivery member configured to engage the distal end portion of the housing when the delivery member is moved in the distal direction relative to the housing to deform the distal end portion of the housing to produce an opening through which the drug-containing tablet can be expelled, the delivery member including a first protrusion configured to engage a portion of the housing to limit movement of the delivery member relative to the housing in a proximal direction, the delivery member including a second protrusion configured to limit movement of the delivery member relative to the housing in the distal direction. 2. The apparatus of claim 1, wherein: the distal end portion of the delivery member includes a sloped surface configured to engage a sloped surface of the distal end portion of the housing when the delivery member is moved in the distal direction relative to the housing to deform the distal end portion of the housing to produce the opening. 3. The apparatus of claim 1, further comprising: a safety member configured to engage the delivery member to limit movement of the delivery member relative to the housing in the distal direction, the safety member being removable. 4. The apparatus of claim 1, wherein: the housing includes a first portion having a distal end portion and a second portion having a distal end portion, the distal end portion of the second portion being at least partially disposed in the distal end portion of the first portion before the delivery member is moved in the distal direction to produce the opening, and the volume configured to contain the drug-containing tablet is at least partially defined between the distal end portion of the first portion of the housing and the distal end portion of the second portion of the housing before the delivery member is moved in the distal direction to produce the opening. 5. The apparatus of claim 4, wherein the distal end portion of the delivery member is configured engage the distal end portion of the second portion of the housing when the delivery member is moved in the distal direction relative to the housing to produce the opening. 6. The apparatus of claim 1, wherein: the housing includes a first portion and a second portion, the first portion and second portion collectively define the actuation pathway longitudinally extended between the first portion of the housing and the second portion of the housing, at least one of the first portion of the housing or the second portion of the housing is configured to flexibly deform when the delivery member is moved in the distal direction relative to the housing to produce the opening. 7. The apparatus of claim 1, wherein: the housing includes a bridge configured to engage the delivery member, at least a portion of the bridge configured to be separated from the housing when the delivery member is moved relative to the housing in the distal direction. 8. The apparatus of claim 1, wherein the distal end portion of the delivery member includes a first sloped portion and a second sloped portion and defines a concave portion between the first sloped portion and the second sloped portion. 9. The apparatus of claim 1, further comprising: the drug-containing tablet, the drug-containing tablet being disposed in the volume, the drug-containing tablet including a dosage of sufentanil. 10. The apparatus of claim 9, wherein the drug-containing tablet includes an amount of sufentanil selected from the group consisting of 5 mcg, 10 mcg, 15 mcg, 20 mcg, 30 mcg, 40 mcg, 50 mcg, 60 mcg, 70 mcg, 80 mcg and 100 mcg, and wherein said drug-containing tablet has a volume of less than 30 microliters or a mass less than 30 mg. 11. The apparatus of claim 1, wherein: the housing defines a channel between the actuation pathway and an exterior surface of the housing; and the second protrusion of the delivery member is slidably disposed within the channel, an edge of the second protrusion is configured to limit movement of the delivery member relative to the housing in the distal direction. 12. An apparatus, comprising: a housing including a first portion coupled to a second portion to define an actuation pathway; and a delivery member, a distal end portion of the delivery member including a recessed portion, at least a portion of the delivery member being disposed within the actuation pathway such that the distal end portion of the delivery member including the recessed portion and a distal end portion of the housing define a volume configured to contain a drug-containing tablet, the delivery member configured to move relative to the housing in a distal direction to expel the drug-containing tablet from the volume, the delivery member configured to flexibly deform at least one of the first portion or second portion of the housing when the delivery member is moved in the distal direction relative to the housing to produce an opening through which the drug-containing tablet can be expelled. 13. The apparatus of claim 12, wherein: a deformable distal tip is included in a distal end portion of the first portion of the housing, the distal end portion of the delivery member includes a first sloped surface and a second sloped surface spaced apart from the first sloped surface by the recessed portion, the first sloped surface configured to engage a first side of the distal end portion of the first portion of the housing to flexibly deform the distal tip, and the second sloped surface configured to engage a second side of the distal end portion of the first portion of the housing to flexibly deform the distal tip. 14. The apparatus of claim 12, further comprising: the drug-containing tablet, the drug-containing tablet being disposed in the volume, the volume is defined before the delivery member is moved in the distal direction relative to the housing. 15. The apparatus of claim 12, further comprising: a safety member contacting a portion of the delivery member to limit movement of the delivery member relative to the housing in the distal direction. 16. The apparatus of claim 12, wherein: the housing defines a channel between the actuation pathway and an exterior surface of the housing; and the delivery member includes a protrusion slidably disposed within the channel, the protrusion configured to limit movement of the delivery member relative to the housing in the distal direction. 17. The apparatus of claim 12, wherein the housing includes a bridge member configured to engage the delivery member, the bridge member configured to resist movement of the delivery member relative to the housing in the distal direction, the bridge member configured to deform when a force applied by the delivery member in the distal direction exceeds a predetermined threshold. 18. The apparatus of claim 12, wherein: a proximal end portion of the housing is open at a proximal end portion of the actuation pathway, a proximal end portion of the delivery member is extended from the proximal end portion of the housing when the delivery member is in an unactuated position, and the delivery member includes a protrusion configured to engage a portion of the housing to limit movement of the delivery member relative to the housing in a proximal direction when the delivery member is in the unactuated position. 19. The apparatus of claim 12, further comprising: the drug-containing tablet, the drug-containing tablet being disposed in the volume, the drug-containing tablet including a dosage of sufentanil. 20. The apparatus of claim 12, wherein the housing and delivery member are configured to enable a user to deliver the drug-containing tablet to a sub-lingual mucosal membrane. 21. The apparatus of claim 12, wherein: the distal end portion of at least one of the first portion of the housing or the second portion of the housing includes a deformable distal tip, the delivery member is movable in the distal direction relative to the housing from an unactuated position to an actuated position, the distal end portion of the delivery member including the recessed portion is disposed in the distal end portion of the housing when the delivery member is in the unactuated position, the distal end portion of the delivery member including the recessed portion and the distal end portion of the at least one of the first portion of the housing or the second portion of the housing including the deformable distal tip collectively define, when the delivery member is in the unactuated position, the volume, and the delivery member is configured to flexibly deform the deformable distal tip when the delivery member is moved from the unactuated position to the actuated position to produce the opening. 22. An apparatus, comprising: a housing defining an actuation pathway, the housing having a distal end portion and a proximal end portion, the proximal end portion of the housing defining a first opening; and a delivery member, at least a portion of the delivery member being disposed within the actuation pathway such that (1) a distal end portion of the delivery member is disposed within the distal end portion of the housing, (2) a proximal end portion of the delivery member is extended, in a proximal direction, through the first opening, and (3) the distal end portion of the delivery member and the distal end portion of the housing define a volume configured to contain a drug-containing tablet, at least a portion of the distal end portion of the housing defining the volume including a deformable distal tip, the delivery member configured to move relative to the housing in a distal direction to expel the drug-containing tablet from the volume, the distal end portion of the delivery member configured to engage the distal end portion of the housing when the delivery member is moved in the distal direction relative to the housing to deform the deformable distal tip of the distal end portion of the housing to produce a second opening through which the drug-containing tablet can be expelled, the delivery member including a first protrusion configured to engage a portion of the housing to limit movement of the delivery member relative to the housing in the proximal direction so that the delivery member cannot be removed from the housing through the first opening, the delivery member including a second protrusion configured to limit movement of the delivery member relative to the housing in the distal direction.